Skip to main content

Advertisement

SpringerLink
Log in

Paliperidone palmitate use in pregnancy in a woman with schizophrenia

  • Case Report
  • Published:
Archives of Women's Mental Health Aims and scope Submit manuscript

Abstract

Long-acting antipsychotic use in schizophrenia has become an advantage for treatment compliance and convenient administration of the drugs. There is no data on paliperidone palmitate (PP) use in pregnancy, which is the longest-acting (i.e., 1 month) atypical antipsychotic. In this case report, we aim to present a patient diagnosed with schizophrenia who had been using PP before and during her pregnancy until week 28 of gestation and gave birth to a male baby that weighed 3000 g at 39 weeks. As far as we know, this is the first case report on PP use during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Coverdale JH, Turbort SH, Roberts H (1997) Family planning needs and STD risk behaviours of female psychiatric outpatients. Br J Psychiatry 171:69–72

    Article  CAS  PubMed  Google Scholar 

  • Kim SW, Kim KM, Kim JM, Shin IS, Shin HY, Yang SJ, Yoon JS (2007) Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31:543–545

    Article  CAS  PubMed  Google Scholar 

  • Kramer M, Litman R, Hough D, Lane R, Lim P, Liu Y, Eerdekens M (2010) Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study. Int J Neuropsychopharmacol 13:635–647

    Article  CAS  PubMed  Google Scholar 

  • Miller LJ, Finnrerty M (1996) Sexuality, pregnancy, and childbearing among women with schizophrenia-spectrum disorders. Hosp Community Psychiatry 47:502–506

    CAS  Google Scholar 

  • Nasrallah HA (2007) The case for long-acting antipsychotic agents in the post-CATIE era. Acta Psychiatr Scand 115:260–267

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Akdeniz University School of Medicine, Kampüs, 07059, Antalya, Turkey

    Aslı Karadağ Özdemir, Şima Ceren Pak, Fatih Canan, Ömer Geçici, Murat Kuloğlu & Mustafa Kadri Gücer

Authors
  1. Aslı Karadağ Özdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Şima Ceren Pak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatih Canan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ömer Geçici
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Murat Kuloğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mustafa Kadri Gücer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fatih Canan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özdemir, A.K., Pak, Ş.C., Canan, F. et al. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Arch Womens Ment Health 18, 739–740 (2015). https://doi.org/10.1007/s00737-014-0496-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00737-014-0496-6

Keywords

Search

Navigation